BARDA
BARDA Awards $733K to AAD to Develop Rapid Analyzer For Early Detection of Severe Infection
The firm said its system is being developed to deliver laboratory-grade results in two minutes and for use in urgent care clinics, doctors' offices, and other settings.
BARDA Exercises $6.4M Option on T2 Biosystems Contract
The funding supports development of antimicrobial resistance, biothreat agent, and sepsis pathogen panels, as well as a next-gen instrument.
OraSure Technologies Nabs $13.6M BARDA Funding
The funding will support OraSure's efforts to obtain 510(k) clearance and CLIA waiver for the InteliSwab rapid SARS-CoV-2 antigen test.
Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests
The funding is for the firm's SARS-CoV-2, pan-coronavirus, and multiplex SARS-CoV-2, influenza, and respiratory syncytial virus tests, according to BARDA.
HHS, DoD Award $35.1M to LightDeck Diagnostics to Boost Production of COVID-19 POC Tests
LightDeck said its COVID-19 Ultra-Rapid Antigen and Total Antibody tests will provide lab-quality results within five minutes wherever testing is needed.